TP53 and neoplasm: CTCF has been reported to interact with the promoter region of P53 and prevent the enrichment of chromatin repression markers, such as H3K9me3 and H3K27me3, thereby preserving the transcriptional activity and tumor-suppressing function of P53 in various types of cancer cells [59].